{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:15:01Z","timestamp":1777695301934,"version":"3.51.4"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra region of the midbrain. Diagnostic criteria for PD require that at least two of three motor signs are observed: tremor, rigidity, and\/or bradykinesia. The most common and effective treatment for PD is Levodopa (L-DOPA) which is readily converted to DA and has been the primary treatment since the 1960\u2019s. Dopamine agonists have also been developed but are less effective than L-DOPA. Although the lack of a model system to study PD has hampered efforts to identify treatments, diverse screening strategies have been proposed for identification of new pharmaceutical candidates. Here, we describe a pilot screen to identify candidate molecules from a bioactive compound library, that might increase formation, maintenance and\/or survival of DA neurons <jats:italic>in vitro<\/jats:italic>. The screen used a previously characterized reporter construct consisting of the luciferase gene inserted downstream of the endogenous tyrosine hydroxylase (TH) gene and neurons differentiated from human pluripotent stem cells for 18\u2009days. The reporter mimics expression of TH and includes a secreted luciferase whose activity can be measured non-invasively over multiple timepoints. Screening of the bioactive compound library resulted in the identification of a single molecule, SGC0946, that is an inhibitor of DOT1L (Disruptor Of Telomeric silencing 1-Like) which encodes a widely-conserved histone H3K79 methyltransferase that is able to both activate and repress gene transcription. Our results indicate that SGC0946 increased reporter luciferase activity with a single treatment for 48-h post-plating being equivalent to continuous treatment. Moreover, data suggested that the total number of neurons differentiated in the assays was comparable from experiment to experiment under different SGC0946 treatments over time. In contrast, data suggested that the survival and\/or maintenance of DA neurons might be specifically enhanced by SGC0946 treatment. These results document the feasibility of a set of tools for further exploration of small molecules that may impact DA neuron differentiation, maintenance and\/or survival. Results provide evidence in support of other reports that indicate inhibition of DOT1L may play an important role in maintenance and survival of neural progenitor cells (NPCs) and their lineage-specific differentiation.<\/jats:p>","DOI":"10.3389\/fnagi.2022.1026468","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:50:59Z","timestamp":1670827859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival"],"prefix":"10.3389","volume":"14","author":[{"given":"Jun","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee A.","family":"Reijo Pera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0166-2236(95)80020-3","article-title":"The functional anatomy of disorders of the basal ganglia","volume":"18","author":"Albin","year":"1995","journal-title":"Trends Neurosci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/bioengineering8020030","article-title":"High-throughput screening platforms in the discovery of novel drugs for neurodegenerative diseases","volume":"8","author":"Aldewachi","year":"2021","journal-title":"Bioengineering"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"864612","DOI":"10.3389\/fgene.2022.864612","article-title":"Histone methyltransferase DOT1L as a promising epigenetic target for treatment of solid tumors","volume":"13","author":"Alexandrova","year":"2022","journal-title":"Front. Genet."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"Ns20210021","DOI":"10.1042\/NS20210021","article-title":"\u03b1-Synuclein pathogenesis in hiPSC models of Parkinson\u2019s disease","volume":"5","author":"Baena-Montes","year":"2021","journal-title":"Neuronal. Signals"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3390\/cells9092065","article-title":"Using high-content screening to generate single-cell gene-corrected patient-derived ips clones reveals excess alpha-synuclein with familial Parkinson\u2019s disease point mutation A30P","volume":"9","author":"Barbuti","year":"2020","journal-title":"Cells"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s12015-022-10390-4","article-title":"Cutting the mustard with induced pluripotent stem cells: an overview and applications in healthcare paradigm","volume":"18","author":"Behl","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e26159","DOI":"10.1371\/journal.pone.0026159","article-title":"SNCA triplication Parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumlate \u03b1-synuclein and are susceptible to oxidative stress","volume":"6","author":"Byers","year":"2011","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuroimage.2015.03.079","article-title":"Direct in vivo assessment of human stem cell graft-host neural circuits","volume":"114","author":"Byers","year":"2015","journal-title":"Neuroimage"},{"key":"ref500","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.slasd.2022.05.001","article-title":"A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins","volume":"27","author":"Casalino","year":"2022","journal-title":"SLAS Discov."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"25181","DOI":"10.1038\/srep25181","article-title":"Quantification of dopaminergic neuron differentiation and neurotoxicity via a genetic reporter","volume":"6","author":"Cui","year":"2016","journal-title":"Sci. Rep."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3389\/fnins.2018.00976","article-title":"The utility of zebrafish as a model for screening developmental neurotoxicity","volume":"12","author":"D\u2019amora","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-981-32-9755-5_11","article-title":"Drug screening platforms and RPPA","volume":"1188","author":"Dawson","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092402","article-title":"Induced pluripotent stem cell-derived dopaminergic neurons from familial Parkinson\u2019s disease patients display \u03b1-synuclein pathology and abnormal mitochondrial morphology","volume":"10","author":"Diao","year":"2021","journal-title":"Cells"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","article-title":"Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation","volume":"2","author":"Doi","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.stemcr.2022.08.010","article-title":"Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson\u2019s disease","volume":"17","author":"Drouin-Ouellet","year":"2022","journal-title":"Stem Cell Rep."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"108263","DOI":"10.1016\/j.celrep.2020.108263","article-title":"Single-cell transcriptomics of Parkinson\u2019s disease human in vitro models reveals dopamine neuron-specific stress responses","volume":"33","author":"Fernandes","year":"2020","journal-title":"Cell Rep."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.1038\/s41467-020-19001-7","article-title":"DOT1L-mediated murine neuronal differentiation associates with H3K79me2 accumulation and preserves SOX2-enhancer accessibility","volume":"11","author":"Ferrari","year":"2020","journal-title":"Nat. Commun."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/2211-5463.13060","article-title":"Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson\u2019s disease patient (PARK4) with SNCA triplication","volume":"11","author":"Fukusumi","year":"2021","journal-title":"FEBS Open Bio."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/srep01463","article-title":"Deriving dopaminergic neurons for clinical use. A practical approach","volume":"3","author":"Gonzalez","year":"2013","journal-title":"Sci. Rep."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13041-020-00623-3","article-title":"Differentiation and localization of interneurons in the developing spinal cord depends on DOT1L expression","volume":"13","author":"Gray De Cristoforis","year":"2020","journal-title":"Mol. Brain"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","article-title":"Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson\u2019s disease","volume":"15","author":"Grealish","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41598-021-04131-9","article-title":"Two-step screening method to identify \u03b1-synuclein aggregation inhibitors for Parkinson\u2019s disease","volume":"12","author":"Hideshima","year":"2022","journal-title":"Sci. Rep."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"15209","DOI":"10.1073\/pnas.2001305117","article-title":"Impact of alpha-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized alpha-synuclein rat model of PD","volume":"117","author":"Hoban","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref600","doi-asserted-by":"publisher","first-page":"13288","DOI":"10.1021\/acs.jmedchem.2c01113","article-title":"Chemical Toolkit for PARK7: Potent, Selective, and High-Throughput","volume":"65","author":"Jia","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41531-022-00354-3","article-title":"LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson\u2019s disease","volume":"8","author":"Kedariti","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/nsmb.2372","article-title":"5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary","volume":"19","author":"Khare","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.stem.2021.01.005","article-title":"Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use","volume":"28","author":"Kim Tw","year":"2021","journal-title":"Cell Stem Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.2174\/09298673113209990001","article-title":"Virtual screening strategies in drug discovery: a critical review","volume":"20","author":"Lavecchia","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e3881","DOI":"10.21769\/BioProtoc.3881","article-title":"A Parkinson\u2019s disease-relevant mitochondrial and neuronal morphology high-throughput screening assay in LUHMES cells","volume":"11","author":"Leah","year":"2021","journal-title":"Biol. Protoc."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40478-021-01203-9","article-title":"In Parkinson\u2019s patient-derived dopamine neurons, the triplication of \u03b1-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition","volume":"9","author":"Lin","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stem.2011.01.013","article-title":"LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress","volume":"8","author":"Nguyen","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/cells10040931","article-title":"A propagated skeleton approach to high throughput screening of neurite outgrowth for in vitro Parkinson\u2019s disease modeling","volume":"10","author":"Schikora","year":"2021","journal-title":"Cells"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bpa.12526","article-title":"Modeling Parkinson\u2019s disease with induced pluripotent stem cells harboring \u03b1-synuclein mutations","volume":"27","author":"Singh","year":"2017","journal-title":"Brain Pathol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.biotechadv.2016.12.002","article-title":"Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening","volume":"35","author":"Smith","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41531-022-00366-z","article-title":"Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson\u2019s disease patients","volume":"8","author":"Stern","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2174\/156720181105140922123751","article-title":"Pluripotency and targeted reprogramming: strategies, disease modeling and drug screening","volume":"11","author":"Stewart","year":"2014","journal-title":"Curr. Drug Deliv."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/stem.499","article-title":"Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. `","volume":"28","author":"Swistowski","year":"2010","journal-title":"Stem Cells"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/nn.2959","article-title":"5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nature neuroscience 14, 1607-1616","volume":"14","author":"Szulwach","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cells"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cells"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"906713","DOI":"10.3389\/fcell.2022.906713","article-title":"Connecting the DOTs on cell identity","volume":"10","author":"Wille","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"ref46","first-page":"2823","article-title":"The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target","volume":"5","author":"Wong","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1101\/gad.2036011","article-title":"Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells","volume":"25","author":"Wu","year":"2011","journal-title":"Genes Dev."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.celrep.2017.02.023","article-title":"Characterization of dopaminergic neurons derived from a tyrosine hydroxylase reporter stem cell line. Cell reports 18, 2533-46","volume":"18","author":"Xia","year":"2017","journal-title":"Cell Rep."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"20270","DOI":"10.1038\/srep20270","article-title":"Transcriptional comparison of human induced and primary midbrain dopaminergic neurons","volume":"6","author":"Xia","year":"2016","journal-title":"Sci. Rep."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1634\/stemcells.2007-0494","article-title":"Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats","volume":"26","author":"Yang","year":"2008","journal-title":"Stem Cells"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"51737","DOI":"10.3791\/51737","article-title":"Directed dopaminergic neuron differentiation from human pluripotent stem cells","volume":"91","author":"Zhang","year":"2014","journal-title":"J. Vis. Exp."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.1026468\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:51:09Z","timestamp":1670827869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.1026468\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":53,"alternative-id":["10.3389\/fnagi.2022.1026468"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.1026468","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"article-number":"1026468"}}